UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study

Arthritis research & therapy, 2019-03, Vol.21 (1), p.76-76, Article 76

2019

Volltextzugriff (PDF)

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

Trials, 2021-01, Vol.22 (1), p.1-3, Article 1

2021

Volltextzugriff (PDF)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

Frontiers in immunology, 2020-08, Vol.11, p.2072-2072

2020

Volltextzugriff (PDF)

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

Frontiers in immunology, 2021-10, Vol.12, p.765330-765330

2021

Volltextzugriff (PDF)

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

Frontiers in immunology, 2023-10, Vol.14, p.1255292-1255292

2023

Volltextzugriff (PDF)

Delayed‐type allergy to cobalt—comparison of a flow cytometric lymphocyte proliferation test with patch testing

Contact dermatitis, 2018-07, Vol.79 (1), p.31-33

2018

Volltextzugriff (PDF)

Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients

Frontiers in immunology, 2020-12, Vol.11, p.613130

2020

Volltextzugriff (PDF)

A ‘Too Negative’ ANA Test Predicts Antibody Deficiency

Journal of clinical immunology, 2016-05, Vol.36 (4), p.374-376

2016

Volltextzugriff (PDF)

A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury

JACC. Cardiovascular interventions, 2020-04, Vol.13 (7), p.833-842

2020

Volltextzugriff (PDF)

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

Journal of clinical oncology, 2016-02, Vol.34 (5), p.495-500

2016

Volltextzugriff (PDF)

The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned

Autoimmunity reviews, 2021-12, Vol.20 (12), p.102985, Article 102985

2021

Volltextzugriff (PDF)

Mice Lacking IL-12 Develop Polarized Th1 Cells During Viral Infection

The Journal of immunology (1950), 1998-04, Vol.160 (8), p.3958-3964

1998

Volltextzugriff (PDF)

Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy

Clinical and experimental rheumatology, 2012-03, Vol.30 (2), p.240

2012

Volltextzugriff (PDF)

A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients

Blood coagulation & fibrinolysis, 2003-01, Vol.14 (1), p.99-106

2003

Volltextzugriff (PDF)

Recombinant human C1 esterase inhibitor

Trials, 2021-01, Vol.22 (1)

2021

Volltextzugriff (PDF)

Enumeration of antigen‐specific CD8+ T lymphocytes by single‐platform, HLA tetramer‐based flow cytometry: A European multicenter evaluation

Cytometry. Part B, Clinical cytometry, 2004-11, Vol.62B (1), p.1-13

2004

Volltextzugriff (PDF)

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study

Clinical and experimental rheumatology, 2013-03, Vol.31 (2 Suppl 76), p.96

2013

Volltextzugriff (PDF)

Diagnosis of stinging insect allergy: utility of cellular in-vitro tests

Current opinion in allergy and clinical immunology, 2009-08, Vol.9 (4), p.343-350

2009

Volltextzugriff (PDF)

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Blood, 2000-11, Vol.96 (10), p.3544-3552

2000

Volltextzugriff (PDF)

Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16)

The Journal of immunology (1950), 1998-09, Vol.161 (6), p.3026-3032

1998

Volltextzugriff (PDF)

Lysis of murine B lymphoma cells by transgenic phagocytes via a human FcγRI×murine MHC class II bispecific antibody

Cancer Immunology, Immunotherapy, 1997-11, Vol.45 (3-4), p.166-170

1997

Volltextzugriff (PDF)

Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies

Cancer research (Chicago, Ill.), 1999-11, Vol.59 (22), p.5778-5784

1999

Volltextzugriff (PDF)

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Blood, 2000-11, Vol.96 (10), p.3544-3552

2000

Volltextzugriff (PDF)

Human IgG Fc Receptors

International reviews of immunology, 1997, Vol.16 (1-2), p.29-55

1997

Volltextzugriff (PDF)

Abdominal pain, indigestion and eosinophilia

Revue médicale suisse, 2006-03, Vol.2 (57), p.749

2006

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(35)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

Delayed‐type allergy to cobalt—comparison of a flow cytometric lymphocyte proliferation test with patch testing

Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients

A ‘Too Negative’ ANA Test Predicts Antibody Deficiency

A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03

The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned

Mice Lacking IL-12 Develop Polarized Th1 Cells During Viral Infection

Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy

A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients

Recombinant human C1 esterase inhibitor

Enumeration of antigen‐specific CD8+ T lymphocytes by single‐platform, HLA tetramer‐based flow cytometry: A European multicenter evaluation

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study

Diagnosis of stinging insect allergy: utility of cellular in-vitro tests

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16)

Lysis of murine B lymphoma cells by transgenic phagocytes via a human FcγRI×murine MHC class II bispecific antibody

Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Human IgG Fc Receptors

Abdominal pain, indigestion and eosinophilia

Suchergebnisse filtern